腹腔镜胆总管探查取石免留置鼻胆管引流一期缝合术临床疗效的多中心回顾性研究(附312例报告)

Clinical efficacies of free endoscopic nasobiliary drainage in primary duct closure following laparoscopic common bile duct exploration: a multicenter retrospective study (A report of 312 cases)

  • 摘要: 目的:探讨腹腔镜胆总管探查取石免留置鼻胆管引流一期缝合术的临床疗效。
    方法:采用回顾性队列研究方法。收集2011年1月至2017年6月国内11家肝胆胰疾病治疗中心收治的肝外胆管结石伴或不伴胆囊结石312例[华中科技大学同济医学院附属同济医院86例、浙江大学医学院附属第二医院62例、四川大学华西医院44例、西安交通大学第一附属医院29例、陆军军医大学(第三军医大学)第一附属医院27例、湖南省人民医院25例、首都医科大学附属北京友谊医院17例、海南医学院第一附属医院10例、河南省人民医院5例、首都医科大学附属北京天坛医院4例、福建医科大学附属第一医院3例]患者的临床资料。312例患者中,231例未留置鼻胆管引流,设为一期缝合组;81例留置鼻胆管引流,设为鼻胆管引流组。所有患者行腹腔镜胆总管探查取石胆总管一期缝合术。观察指标:(1)手术情况比较。(2)术后恢复情况比较。(3)术后并发症比较。(4)随访情况。采用门诊和电话方式进行随访,了解患者术后并发症情况。随访时间截至2017年6月。正态分布的计量资料以±s表示,组间比较采用t检验。偏态分布的计量资料以M(四分位距)表示,组间比较采用非参数检验。计数资料比较采用x2检验或Fisher确切概率法。
    结果:(1)手术情况比较:312例患者均成功行腹腔镜胆总管探查取石胆总管一期缝合术,无一例中转开腹,其中一期缝合组1例术后死亡。一期缝合组和鼻胆管引流组患者的胆总管直径、胆总管缝合方式(间断缝合和连续缝合)、缝线材料(可吸收缝线和不可吸收缝线)分别为(1.2±0.4)cm,间断缝合106例、连续缝合125例,可吸收缝线195例、不可吸收缝线36例和(1.1±0.5)cm,间断缝合76例、连续缝合5例,可吸收缝线79例、不可吸收缝线2例,两组上述指标比较,差异均有统计学意义(t=2.497,x2=56.706,8.457,P<0.05);一期缝合组患者结石数目、结石直径、胆总管壁厚度(≤3 mm和>3 mm)、Oddi括约肌收缩功能(功能良好和功能异常)、术中出血量、手术时间分别为(2.1±1.7)枚,(1.1±0.6)cm,148例、83例,226例、5例,20 mL(10~45 mL),(116±49)min,鼻胆管引流组患者分别为(1.9±1.6)枚,(1.0±0.6)cm,49例、32例,75例、6例,20 mL (15~30 mL),(113±23)min,两组上述指标比较,差异均无统计学意义(t=1.021,0.329,x2=0.329,3.428,Z=1.147,t=0.521,P>0.05)。进一步分析发现:312例患者中胆总管间断缝合182例,连续缝合130例,两种缝合方式手术时间分别为(133±49)min和(103±34)min,两者比较,差异有统计学意义(t=-6.605,P<0.05);两种缝合方式术中出血量和术后并发症分别为20 mL(15~31 mL)、21例和20 mL(10~45 mL)、18例,两者比较,差异均无统计学意义(Z=-0.285,x2=0.369,P>0.05)。312例患者中采用可吸收缝线缝合胆总管274例,不可吸收缝线38例,两种手术缝线材料的术中出血量、手术时间和术后并发症分别为20 mL(15~40 mL)、(116±44)min、33例和18 mL(10~26 mL)、(115±35)min、6例,两者比较,差异均无统计学意义(Z=0.971,t=0.023,x2=0.154,P>0.05)。(2)术后恢复情况比较:一期缝合组和鼻胆管引流组患者在术后胃肠道功能恢复时间、腹腔引流管拔除时间、抗生素使用时间、住院时间分别为(2.0±1.5)d、(4.0±2.4)d、(4.0±2.8)d、(5.5±3.0)d和(4.0±1.9)d、(6.9±3.5)d、(10.0±3.9)d、(11.1±3.7)d,两组上述指标比较,差异均有统计学意义(t=-9.507,-8.258,-15.103,-13.575,P<0.05)。华中科技大学同济医学院附属同济医院一期缝合组和鼻胆管引流组患者总住院费用分别为(5.1±0.6)万元和(6.5±0.5)万元,两组比较,差异有统计学意义(t=-9.516,P<0.05)。(3)术后并发症比较:一期缝合组患者并发症发生率为14.29%(33/231),其中胆瘘16例、胆道感染11例、切口感染3例、胆道出血1例、胆总管结石残留1例、术后死亡1例;鼻胆管引流组患者并发症发生率为6.17%(5/81),其中胆瘘2例、胆道感染2例、胆道出血1例,两组并发症发生率比较,差异无统计学意义(x2=3.151,P>0.05)。(4)随访情况:312例患者中252例获得术后随访,其中一期缝合组175例,鼻胆管引流组77例,失访60例,随访时间为2~67个月,中位随访时间为15个月。随访期间,患者均未出现黄疸、胆管炎和胰腺炎等症状,复查腹部彩色多普勒超声或CT或MRCP检查均未见胆管结石复发及术后胆管狭窄。
    结论:在严格掌握手术适应证的条件下,免留置鼻胆管引流的腹腔镜胆总管探查取石一期缝合术安全和有效。

     

    Abstract: Objective:To investigate the clinical efficacies of free endoscopic nasobiliary drainage (ENBD) in primary duct closure (PDC) following laparoscopic common bile duct exploration (LCBDE) for choledocholithiasis.
    Methods:The retrospective cohort study was conducted. The clinical data of 312 patients with extrahepatic bile duct stones accompanied with or without cholecystolithiasis who were admitted to the 11 medical centers [86 in the Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 62 in the Second Affiliated Hospital of Zhejiang University School of Medicine, 44 in the West China Hospital of Sichuan University, 29 in the First Affiliated Hospital of Xi′an Jiaotong University, 27 in the First Hospital Affiliated to Army Medical University (Third Military Medical University), 25 in the Hunan Provincial People′s Hospital, 17 in the Beijing Friendship Hospital of Capital Medical University, 10 in the First Affiliated Hospital of Hainan Medical University, 5 in the Henan Provincial People′s Hospital, 4 in the Beijing Tian Tan Hospital of Capital Medical University, 3 in the First Affiliated Hospital of Fujian Medical University] from January 2011 to June 2017 were collected. All patients underwent LCBDE+PDC, and 81 and 231 patients with and without ENBD were respectively allocated into the ENBD group and PDC group. Observation indicators: (1) comparisons of operation situations; (2) comparisons of postoperative recovery; (3) comparisons of postoperative complications; (4) follow-up situations. Follow-up using outpatient examination and telephone interview was performed to detect the postoperative complications up to June 2017. Measurement data with normal distribution were represented as ±s. Comparison between groups was analyzed by the t test. Measurement data with skewed distribution were represented M [interquartile range (IQR)], and comparison between groups was analyzed by the nonparametic test. Comparisons of count data were analyzed using the chi-square test and Fisher exact probability.
    Results:(1) Comparisons of operation situations: all the 312 patients underwent successful laparoscopic LCBDE + PDC, without conversion to open surgery, including postoperative death of 1 patient in the PDC group. The common bile duct diameter, cases using interrupted sutures, continuous sutures, absorbable threads and non-absorbable threads were respectively (1.2±0.4)cm, 106, 125, 195, 36 in the PDC group and (1.1±0.5)cm, 76, 5, 79, 2 in the ENBD group, with statistically significant differences between groups (t=2.497, x2=56.706, 8.457, P<0.05). The numbers of stones, stone diameter, cases with common bile duct wall (≤3 mm and >3 mm), normal and abnormal Oddi sphincter contraction function, volume of intraoperative blood loss and operation time were respectively 2.1±1.7, (1.1±0.6)cm, 148, 83, 226, 5, 20 mL (10-45 mL), (116±49)minutes in the PDC group and 1.9±1.6, (1.0±0.6)cm, 49, 32, 75, 6, 20 mL (15-30 mL), (113±23)minutes in the ENBD group, with no statistically significant difference between groups (t=1.021, 0.329, x2=0.329, 3.428, Z=1.147, t=0.521, P>0.05). The further analysis: of 312 patients, cases and time using interrupted sutures and continuous sutures were respectively 182, 130 and (133±49)minutes, (103±34)minutes,with a statistically significant difference between groups (t=-6.605, P<0.05). The volume of intraoperative blood loss and cases with postoperative complications using interrupted sutures and continuous sutures were respectively 20 mL (15-31 mL), 21 and 20 mL (10-45 mL), 18, with no statistically significant difference between groups (Z=-0.285, x2=0.369, P>0.05). Of 312 patients, cases, operation time, volume of intraoperative blood loss and postoperative complications using absorbable threads and non-absorbable threads were respectively 274, (116±44)minutes, 20 mL (15-40 mL), 33 and 38, (115±35)minutes, 18 mL (10-26 mL), 6, with no statistically significant difference between groups (Z=0.971, t=0.023, x2=0.154, P>0.05). (2) Comparisons of postoperative recovery: recovery time of gastrointestinal function, time of abdominal drainage-tube removal, using time of antibiotics and duration of hospital stay were respectively (2.0±1.5)days, (4.0±2.4)days, (4.0±2.8)days, (5.5±3.0)days in the PDC group and (4.0±1.9)days, (6.9±3.5)days, (10.0±3.9)days, (11.1±3.7)days in the ENBD group, with statistically significant differences between groups (t=-9.507,-8.258,-15.103,-13.575, P<0.05). The total expenses of hospital stay in the Affiliated Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology were respectively (5.1±0.6)×104 yuan in the PDC group and (6.5±0.5)×104 yuan in the ENBD group, with a statistically significant difference between groups (t=-9.516, P<0.05). (3) Comparisons of postoperative complications: incidence of complications in the PDC group was 14.29%(33/231), including 16 with biliary fistula, 11 with biliary tract infection, 3 with wound infection, 1 with biliary tract bleeding, 1 with residual stones of common bile duct and 1 with death; incidence of complications in the ENBD group was 6.17%(5/81), including 2 with biliary fistula, 2 with biliary tract infection and 1 with biliary tract bleeding, showing no statistically significant difference between groups (x2=3.151, P>0.05). (4) Follow-up situations: of 312 patients, 252 were followed up for 2-67 month, with a median time of 15 months, including 175 in the PDC group and 77 in the ENBD group. During the follow-up, there was no occurrence of jaundice, cholangitis and pancreatitis, and stone recurrence and postoperative cholangiostenosis were not detected by abdominal color Doppler ultrasound or CT or magnetic resonanced cholangio-pancreatography.
    Conclusion:On the basis of grasping operative indication strictly, ENBD in PDC following LCBDE for choledocholithiasis is safe and effective.

     

/

返回文章
返回